Business Wire||September 23, 2016
New clinical trial shows excellent patency consistent with previous study results.
W. L. Gore & Associates||September 19, 2016
Enrollment begins on clinical study for first device designed for the endovascular treatment of aortic arch lesions.
W. L. Gore & Associates, Inc||September 7, 2016
The stent-graft has evolved to address range of indications and patient needs.
W. L. Gore & Associates Inc.||August 30, 2016
New sheath provides exceptional access to challenging anatomies and branch vessels.
Businesswire||August 4, 2016
The stent has been designed to weather biomechanical forces.
W. L. Gore & Associates Inc.||August 2, 2016
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies.
Business Wire||June 28, 2016
Study illustrates role device can play in maintaining and salvaging failing dialysis circuits.
Business Wire||June 7, 2016
Antegrade iteration accepted into the study, advancing the branched, all-in-one system.
Business Wire||June 3, 2016
Device expands clinicians’ options in the endovascular treatment of patients with aortic disease.
Business Wire||April 25, 2016
Unique biomaterial for hernia repair implanted for the first time in Gore’s clinical quality improvement project.
Business Wire||April 22, 2016
Regulatory consent expands the company's global reach.
W.L. Gore & Associates||March 25, 2016
New research methodology will procure real world feedback from surgeons and patients.
W.L. Gore & Associates Inc.||March 4, 2016
All-in-one system is designed to preserve iliac artery blood flow.
Business Wire||January 19, 2016
Gore Synecor Biomaterial combines strength of PTFE with the tissue-building scaffold of Gore Bio-A Web.
Sign up now to receive the free weekly newsletter, and more!